CORR Insights®: Is a Nomogram Able to Predict Postoperative Wound Complications in Localized Soft-tissue Sarcomas of the Extremity?

In the current study, Bedi and colleagues [1] provided a novel method to predict an individual’s risk of postoperative wound complications in localized soft-tissue sarcomas of the extremity. After controlling for confounding variables, they found that increasing age, higher BMI, tumor location in the lower extremity, and use of neoadjuvant (preoperative) radiotherapy were associated with an increased likelihood that a wound complication would arise, which is consistent with several large retrospective studies [5, 10, 11]. Although the 5-year local control rates for soft-tissue sarcoma of the extremity could be 88% or higher [4, 8, 12], wound complications following limb sparing surgery combined with radiotherapy are as high as 30.2% [10], and complications of this sort can compromise limb function and diminish a patient’s quality of life. The other studies that have evaluated factors associated with wound complications after extremity soft-tissue sarcoma resection also found smoking, diabetes, flap reconstruction, and increasing tumor size might be associated with an increased risk of wound complications as well [5, 10, 11]. In general, these factors can be categorized into three types: Patient-related (elements like BMI and diabetes), tumor-related (tumor volume and location), and treatmentrelated (neoadjuvant radiotherapy and flap reconstruction). Where Do We Need to Go?

[1]  K. Chouliaras,et al.  Is a Nomogram Able to Predict Postoperative Wound Complications in Localized Soft-tissue Sarcomas of the Extremity? , 2020, Clinical orthopaedics and related research.

[2]  J. Wunder,et al.  Risk factors for postoperative wound complications after extremity soft tissue sarcoma resection: A systematic review and meta-analyses. , 2019, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[3]  J. Blay,et al.  Safety and efficacy of Pazopanib in advanced soft tissue sarcoma: PALETTE (EORTC 62072) subgroup analyses , 2019, BMC Cancer.

[4]  R. Castelein,et al.  Soft tissue sarcoma of the hand: Is unplanned excision a problem? , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[5]  Peter Hohenberger,et al.  Neoadjuvant Pazopanib Treatment in High-Risk Soft Tissue Sarcoma: A Quantitative Dynamic 18F-FDG PET/CT Study of the German Interdisciplinary Sarcoma Group , 2019, Cancers.

[6]  A. D. Dei Tos,et al.  Soft tissue sarcoma in Italy: From epidemiological data to clinical networking to improve patient care and outcomes. , 2019, Cancer epidemiology.

[7]  H. V. van Boven,et al.  Time dependent dynamics of wound complications after preoperative radiotherapy in Extremity Soft Tissue Sarcomas. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[8]  E. Bastiaannet,et al.  Identification of predictors for wound complications following preoperative or postoperative radiotherapy in extremity soft tissue sarcoma. , 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[9]  K. Delman,et al.  The Oncologic Impact of Postoperative Complications Following Resection of Truncal and Extremity Soft Tissue Sarcomas , 2017, Annals of Surgical Oncology.

[10]  J. Blay,et al.  Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial. , 2016, The Lancet. Oncology.

[11]  D. Kirsch,et al.  Radiation Therapy for Soft Tissue Sarcoma: Indications and Controversies for Neoadjuvant Therapy, Adjuvant Therapy, Intraoperative Radiation Therapy, and Brachytherapy. , 2016, Surgical oncology clinics of North America.

[12]  A. Davis,et al.  Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial , 2002, The Lancet.